HIF1A and cancer: Crosstalk between hypoxic cancer cells secreting VEGF-A under the control of HIF1α and ECs expressing the VEGF receptor 2 (VEGFR2), triggers EC proliferation and migration, thereby leading to enhanced neo-vascularization [7,52].